Cargando…
Duloxetine for the treatment of generalized anxiety disorder: a review
Approximately 16 million people in the United States suffer from anxiety disorders alone, while another 12 million experience both anxiety and at least one other psychiatric condition. Generalized anxiety disorder (GAD) has lifetime prevalence rates between 5% and 6%. Treatment of GAD is aimed prima...
Autores principales: | Khan, Ahsan Y, Macaluso, Matthew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695226/ https://www.ncbi.nlm.nih.gov/pubmed/19557096 |
Ejemplares similares
-
Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008) -
The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008) -
Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007) -
New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008) -
Role of pregabalin in the treatment of generalized anxiety disorder
por: Baldwin, David S, et al.
Publicado: (2007)